These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 123921)

  • 1. Physical and chemical properties of the NH2-terminal glutamic acid and lysine forms of human plasminogen and their derived plasmins with an NH2-terminal lysine heavy (A) chain.
    Robbins KC; Boreisha IG; Arzadon L; Summaria L
    J Biol Chem; 1975 Jun; 250(11):4044-7. PubMed ID: 123921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of the affinity chromatography forms of human Glu- and Lys-plasminogens and plasmins.
    Summaria L; Spitz F; Arzadon L; Boreisha IG; Robbins KC
    J Biol Chem; 1976 Jun; 251(12):3693-9. PubMed ID: 132440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and some properties of the Glu- and Lys-human plasmin heavy chains.
    Gonzalez-Gronow M; Violand BN; Castellino FJ
    J Biol Chem; 1977 Apr; 252(7):2175-7. PubMed ID: 139407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physico-chemical and proenzyme properties of NH2-terminal glutamic acid and NH2-terminal lysine human plasminogen. Influence of 6-aminohexanoic acid.
    Claeys H; Vermylen J
    Biochim Biophys Acta; 1974 Apr; 342(2):351-9. PubMed ID: 4275496
    [No Abstract]   [Full Text] [Related]  

  • 5. Structural relationship between "glutamic acid" and "lysine" forms of human plasminogen and their interaction with the NH2-terminal activation peptide as studied by affinity chromatography.
    Wiman B; Wallén P
    Eur J Biochem; 1975 Jan; 50(3):489-94. PubMed ID: 122932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation pathway of glu-plasminogen to Lys-plasmin by urokinase.
    Takada A; Takada Y
    Thromb Res; 1982 Sep; 27(6):671-7. PubMed ID: 6129717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of human plasminogen by equimolar levels of streptokinase.
    Bajaj AP; Castellino FJ
    J Biol Chem; 1977 Jan; 252(2):492-8. PubMed ID: 137901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of N-terminal peptide of Glu-plasminogen on the activation of Glu-plasminogen and its conversion to Lys-plasminogen.
    Urano T; Takada Y; Takada A
    Thromb Res; 1991 Feb; 61(4):349-59. PubMed ID: 1676546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic properties of plasmins converted from acid-treated and native Glu- and Lys-plasminogens by urokinase.
    Takada A; Takada Y
    Thromb Res; 1981 Mar; 21(6):593-601. PubMed ID: 6455775
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanism of the urokinase-catalyzed activation of human plasminogen.
    Violand BN; Castellino FJ
    J Biol Chem; 1976 Jul; 251(13):3906-12. PubMed ID: 132442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
    Müllertz S; Thorsen S; Sottrup-Jensen L
    Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the esterase and human plasminogen activator activities of various activated forms of human plasminogen and their equimolar streptokinase complexes.
    Wohl RC; Arzadon L; Summaria L; Robbins KC
    J Biol Chem; 1977 Feb; 252(4):1141-7. PubMed ID: 851483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functionally active heavy chain derived from human high molecular weight urokinase.
    Sumi H; Robbins KC
    J Biol Chem; 1983 Jul; 258(13):8014-9. PubMed ID: 6345538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the carboxy-terminal lysine of urokinase on the catalysis of plasminogen activation.
    Lenich C; Pannell R; Gurewich V
    Thromb Res; 1991 Oct; 64(1):69-80. PubMed ID: 1776140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrodynamic studies on the streptokinase complexes of human plasminogen, Val442-plasminogen, plasmin, and the plasmin-derived light (B) chain.
    Barlow GH; Summaria L; Robbins KC
    Biochemistry; 1984 May; 23(11):2384-7. PubMed ID: 6236844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of human normal, full-term, fetal and adult plasminogen by physical and chemical analyses.
    Summaria L
    Haemostasis; 1989; 19(5):266-73. PubMed ID: 2777139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human and bovine plasminogens by the microplasmin and streptokinase complex.
    Shi GY; Change BI; Wu DH; Ha YM; Wu HL
    Thromb Res; 1990 May; 58(3):317-29. PubMed ID: 2141198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of intramolecular interactions in the control of the fibrin affinity and activation of human plasminogen.
    Bányai L; Patthy L
    J Biol Chem; 1984 May; 259(10):6466-71. PubMed ID: 6725259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen binds to plasmin-modulated factor Xa by Ca(2+) - and C-terminal lysine-dependent and -independent interactions.
    Grundy JE; Hancock MA; Meixner SC; MacKenzie RC; Koschinsky ML; Pryzdial EL
    Thromb Haemost; 2007 Jan; 97(1):38-44. PubMed ID: 17200769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.